The original fld (fatty liver dystrophy) mutation arose spontaneously at The Jackson Laboratory in the Animal Resources BALB/cByJ colony in 1981, and was maintained by sibling mating for 47 generations, then backcrossed once in 2001 to a male BALB/cByJ via homozygous ovarian transplant, then sibling mating resumed. Homozygotes can be identified soon after birth by an enlarged, pale liver and smaller overall body size. Although the hepatic steatosis resolves to normal at wean age, a neurological phenotype manifests by day 14 as a tremor and an unsteady gait which is most pronounced in the rear legs (Sweet et al. 1988). Both phenotypes stem from improper cellular processing of lipid.
fld/fld mice are smaller than their normal littermates by three days of age and remain smaller throughout life. Hair growth is retarded and abnormal resulting in a ruffled, unkempt appearance in the adult. Homozygotes experience increased mortality between 19 and 35 days of age. Approximately half of the surviving females will breed, but they do not usually produce a first litter before 3 months of age. Homozygous males rarely breed and thus are generally considered sterile (Sweet et al. 1988; Langner et al., 1989).
Although no architectural changes or inflammation were detected in fatty livers from 12 day old fld/fld mice, the hepatocytes contain huge lipid droplets. Homozygous pups have hypertriglyceridemia with serum triglyceride levels up to 1000 mg/dl. There is a slight increase in diacylglyceride levels but no change in cholesterol, cholesterol ester, or phospholipid levels. Pre-wean pups have a liver-specific increase in mRNA levels for apolipoprotein A IV mRNA and apolipoprotein C-II mRNA that returns to normal in the adult. Hepatic lipase mRNA and serum hepatic lipase activity are decreased until the beginning of wean age. Between 13 and 15 days of age triglyceride levels abruptly drop to normal and at 30 days of age the hepatic lipid levels are normal. This return to normal is not delayed by extending suckling. (Langner et al., 1989).
Quantitative two-dimensional gel electrophoresis of liver extracts from 5 day old fld/fld pups revealed an increase in expression in twenty-two proteins (including keratin, B-actin, g-actin, and apolipoproteinA-IV) and a decrease in expression in two proteins relative to 5 day old wild-type controls. The majority of these proteins normally change their expression levels in response to peroxisome proliferating agents. These differences in protein expression resolve in the adult (Rehnmark et al., 1998) as does liver morphology. Hepatocytes taken from 12-day old fld/fld mice and cultured for 4days continue to show a decrease in hepatic lipase activity, an increase in apolipoproteinA IV mRNA, and an accumulation of lipid indicating that the fld defect is in cellular lipid metabolism. Extracts from these cultured hepatocytes have a lower rate of palmitate oxidation than do extracts from wild-type cultured hepatocytes. Extracts from adult fld/fld cultured hepatocytes have normal levels of palmitate oxidation activity (Rehnmark et al., 1998).
Both the brown and white fat pads of fld/fld mice are vastly reduced in mass, contain a paucity of lipid, and are morphologically distinct compared to wild-type sibling controls (Langner et al., 1989; Reue et al., 2000). This phenotype persists in the adult. The adipocytes are severely depleted of lipid. White adipose tissue has a decrease in lipoprotein lipase (LPL) activity and mRNA as well as a decrease in adipsin mRNA. Brown adipose tissue shows an increase in mRNA for PPARg and aP2 particularly in two-week old mice. Consistent with this decreased adipose fat, fld/fld mice have non-fasting hyperinsulinemia, impaired clearance of glucose, and reduced tissue response to insulin (Reue et al., 2000).
Representational difference analysis identified 22 mRNA species whose expression in liver differs between fld/fld and wild-type controls. In addition to novel sequences including a Ras homologue and a serine/threonine protein kinase homologue, a number of these differentially expressed cDNAs encode actin cytoskeleton-associated proteins such as actin, profilin, alpha-2 actinin, and myosin light chain. While fld/fld preadipocytes respond to serum treatment by normal elongation of actin stress fibers, they fail to develop membrane ruffles in response to insulin treatment (Klingenspor et al., 1999).
Feeding a high fat diet to adult fld/fld mice for 2 weeks did not re-induce hypertriglyceridemia or increases in liver apolipoprotein A-IV greater than in controls (Langner et al., 1989). A separate study looked at the development of aortic lesions in fld/fld adults maintained for 16 weeks on an atherogenic diet and found a 2-fold larger lesion area and more advanced lesions than in wild-type controls (Reue et al., 2000).
The fld/fld mice have a peripheral neuropathy which first presents shortly after 10 days of age as a tremor and unsteady gait which worsens gradually throughout life. When picked up by the tail, fld/fld mice clench their toes and clasp their hind feet together. The fld neuropathy is specific to the peripheral nervous system. Electron microscopy of sciatic nerves revealed thin, poorly compacted myelin sheaths, hypertrophic Schwann cells, myelin debris, degenerating axons, bands of Bugner, and regenerative clusters, but no evidence of inflammation (Langner et al, 1991). Western blot analysis of sciatic nerve from two-three month old fld/fld mice showed a 7-13-fold reduction in myelin P0, a vast increase in apoE, an increase in GAP-43, and no detectable myelin P2. It was also noted that an antibody to neurofilament 68K detected bands of lower molecular mass in fld/fld sciatic nerve extracts than in wild-type suggesting degradation of neurofilament 68K. Furthermore, TLC of fld/fld sciatic nerve lipids revealed decreased levels of phospholipids, glycosphingolipids, and some neutral lipids and increased levels of cholesterol esters. These combined findings support the postulate put forward by Langner et al. that fld/fld peripheral neuropathy involves "dysmyelination and concomitant demyelination" (Langner et al, 1991). In light of the role of insulin in Schwann cell and adipocyte differentiation and metabolism, it is noteworthy that fld/fld mice have been found to have altered insulin responsiveness (Klingenspor et al., 1999).
A spontaneous deletion of the Acads gene occurred on the BALB/cByJ background at approximately the same time the fld mutation arose. However, the Acads mutation is not present in the BALB/cByJ-fld mice (Reue and Cohen 1996. Mammalian Genome).
The fld critical region has been fine-mapped to a 0.42 cM interval on chromosome 12. RT-PCR of liver extracts from 6- and 21-day-old pups revealed an absence in fld/fld liver of transcript from one of the genes in this interval, formerly called Kiaa0188, now known to be the gene encoding lipin. (Peterfy et al. 1999; Peterfy et al. 2001)
|Allele Name||fatty liver dystrophy|
|Allele Synonym(s)||Lpin1fld; fatty liver dystrophy|
|Gene Symbol and Name||Lpin1, lipin 1|
|Gene Synonym(s)||fld; Lipin1; PAP1; mKIAA0188; fatty liver dystrophy|
|Strain of Origin||BALB/cByJ|
|Molecular Note||Three molecular changes have been identified in this allele. A 2 kb deletion encompasses exons 2 and 3 including the translation initiation sequence. An inversion exceeding 40 kb encompasses much of the coding region. An additional 0.5 kb sequence downstream of the inverted 40 kb has been duplicated and inserted in reverse orientation just upstream of this 40 kb inversion. Northern blots of adipose tissue extracts failed to detect mRNA from mice homozygous for this allele.|
When using the fatty liver dystrophy mouse strain in a publication, please cite the originating article(s) and include JAX stock #001592 in your Materials and Methods section.
|Heterozygous for Lpin1<fld>|
We will fulfill your order by providing at least two carriers for each strain ordered. The total number, sex, and genotypes provided will vary, although typically 8 or more animals are provided. Please check genotypes which will be recovered. While the genotypes of all animals produced will be communicated to you prior to scheduling shipment, the genotypes of animals provided may not reflect the mating scheme and genotypes described in the strain description. Animals are typically ready to ship in 11-14 weeks. If a second recovery is required to produce the minimum number of animals, then delivery time would increase to approximately 25 weeks. If we fail to produce animals of the correct genotype, you will not be charged. We cannot guarantee the reproductive success of mice shipped to your facility. If the mice are lost after the first three days (post-arrival) or do not produce progeny at your facility, a new order and fee will be necessary.
Cryorecovery to establish a Dedicated Supply for greater quantities of mice. Mice recovered can be used to establish a dedicated colony to contractually supply you mice according to your requirements. Price by quotation.
"MICE" means mouse strains, their progeny derived by inbreeding or crossbreeding, unmodified derivatives from mouse strains or their progeny supplied by The Jackson Laboratory ("JACKSON"). "PRODUCT(S)" means biological materials supplied by JACKSON, and their derivatives. "SERVICES" means projects conducted by JACKSON for other parties that may include but are not limited to the use of MICE or PRODUCTS. "RECIPIENT" means each recipient of MICE, PRODUCTS, or SERVICES provided by JACKSON including each institution, its employees and other researchers under its control. MICE or PRODUCTS shall not be: (i) used for any purpose other than internal research, (ii) sold or otherwise provided to any third party for any use, or (iii) provided to any agent or other third party to provide breeding or other services. Acceptance of MICE, PRODUCTS or SERVICES from JACKSON shall be deemed as agreement by RECIPIENT to these conditions, and departure from these conditions requires JACKSON’s prior written authorization.
MICE, PRODUCTS AND SERVICES ARE PROVIDED "AS IS". JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of, PRODUCTS or SERVICES, JACKSON will, at its option, provide credit or replacement for the PRODUCT received or the SERVICES provided; JACKSON makes no other representations and this shall be the exclusive remedy of the purchaser. Please note specific policy for live mice.
Consistent with the requirement for a written understanding regarding animal care and use, the JACKSON Animal Care and Use Committee will review the animal care and use protocol(s) associated with any SERVICES to be performed at JACKSON, and JACKSON shall have ultimate responsibility and authority for the care of animals while on site or in JACKSON custody.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS, or SERVICES, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS, or SERVICES from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE, PRODUCTS or SERVICES are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or SERVICES. In addition, special terms and conditions of sale of certain MICE, PRODUCTS, or SERVICES may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and SERVICES by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or SERVICES shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or SERVICES by JACKSON.